Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

BMRN

BioMarin Pharmaceutical (BMRN)

BioMarin Pharmaceutical Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:BMRN
DateTimeSourceHeadlineSymbolCompany
12/03/20246:15PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BMRNBioMarin Pharmaceutical Inc
11/16/202410:45AMPR Newswire (US)BioMarin Presents Real-World Evidence Further Supporting Safety and Efficacy of VOXZOGO® (vosoritide) in Children with Achondroplasia at the European Society for Paediatric Endocrinology (ESPE) Meeting 2024NASDAQ:BMRNBioMarin Pharmaceutical Inc
11/14/20242:44PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BMRNBioMarin Pharmaceutical Inc
11/12/20242:27PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:BMRNBioMarin Pharmaceutical Inc
11/06/20248:00AMPR Newswire (US)BioMarin to Participate in Three Upcoming Investor ConferencesNASDAQ:BMRNBioMarin Pharmaceutical Inc
10/31/20243:01PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:BMRNBioMarin Pharmaceutical Inc
10/29/20244:04PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:BMRNBioMarin Pharmaceutical Inc
10/29/20244:03PMPR Newswire (US)BioMarin Announces 28% Y/Y Total Revenue Growth in the Third Quarter and Increase in Full-year 2024 Guidance; Reaffirms Long-term Guidance and OutlookNASDAQ:BMRNBioMarin Pharmaceutical Inc
10/24/20247:00AMGlobeNewswire Inc.Monopar Announces Agreement with Alexion, AstraZeneca Rare Disease For Late-Stage Wilson Disease Drug CandidateNASDAQ:BMRNBioMarin Pharmaceutical Inc
10/16/20248:30AMPR Newswire (US)BioMarin to Host Third Quarter 2024 Financial Results Conference Call and Webcast on Tuesday, October 29, 2024, at 4:30pm ETNASDAQ:BMRNBioMarin Pharmaceutical Inc
10/01/20244:51PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BMRNBioMarin Pharmaceutical Inc
10/01/20244:50PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:BMRNBioMarin Pharmaceutical Inc
09/30/20244:29PMEdgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:BMRNBioMarin Pharmaceutical Inc
09/24/20248:31AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:BMRNBioMarin Pharmaceutical Inc
09/18/20248:00AMPR Newswire (US)BioMarin to Present Data Underscoring Sustained Positive Impact of VOXZOGO® (vosoritide) on Health-Related Quality of Life, Growth and Maintenance of Bone Strength in Children with Achondroplasia at 2024 International Skeletal Dysplasia Society MeetingNASDAQ:BMRNBioMarin Pharmaceutical Inc
09/17/20245:54PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BMRNBioMarin Pharmaceutical Inc
09/04/20241:00PMPR Newswire (US)BioMarin Holds Investor Day; Provides New Corporate Strategy and Introduces 2027 Financial GuidanceNASDAQ:BMRNBioMarin Pharmaceutical Inc
09/04/202412:52PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:BMRNBioMarin Pharmaceutical Inc
09/04/20247:30AMPR Newswire (US)BioMarin to Host Investor Day Today at 10:30 a.m. Eastern TimeNASDAQ:BMRNBioMarin Pharmaceutical Inc
08/29/20248:00AMPR Newswire (US)BioMarin to Present at the 22nd Annual Morgan Stanley Global Healthcare Conference on Thursday, September 5 at 7:45 AM PT / 10:45 AM ET in New York, NYNASDAQ:BMRNBioMarin Pharmaceutical Inc
08/28/20245:02PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:BMRNBioMarin Pharmaceutical Inc
08/22/20245:00PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:BMRNBioMarin Pharmaceutical Inc
08/21/20248:30AMPR Newswire (US)BioMarin Announces New R&D and Business Development LeadershipNASDAQ:BMRNBioMarin Pharmaceutical Inc
08/19/20249:00AMPR Newswire (US)BioMarin to Host 2024 Investor Day on September 4th in New YorkNASDAQ:BMRNBioMarin Pharmaceutical Inc
08/15/20243:57PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BMRNBioMarin Pharmaceutical Inc
08/13/202411:48AMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:BMRNBioMarin Pharmaceutical Inc
08/05/20244:35PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:BMRNBioMarin Pharmaceutical Inc
08/05/20244:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:BMRNBioMarin Pharmaceutical Inc
08/05/20244:03PMPR Newswire (US)BioMarin Announces 20% Y/Y Total Revenue Growth in the Second Quarter and Increase in Full-year 2024 GuidanceNASDAQ:BMRNBioMarin Pharmaceutical Inc
08/05/20244:01PMPR Newswire (US)BioMarin Announces Updated Strategy for ROCTAVIAN® to Focus on U.S., Germany and ItalyNASDAQ:BMRNBioMarin Pharmaceutical Inc
 Showing the most relevant articles for your search:NASDAQ:BMRN

Your Recent History

Delayed Upgrade Clock